Research by Children’s Hospital Colorado signals optimistic outcomes of surgical intervention for Type 2 diabetes Read more
Regeneron and Sanofi declare plans to make Praluent more accessible for patients at high risk Read more
Janssen Pharmaceutical’s INVOKANA alleviates risk of CV death or HHF in type 2 diabetes patients Read more